A Comparative Study of Orally Delivered PBCA and ApoE Coupled BSA Nanoparticles for Brain Targeting of Sumatriptan Succinate in Therapeutic Management of Migraine
Crossref DOI link: https://doi.org/10.1007/s11095-016-1910-8
Published Online: 2016-03-22
Published Print: 2016-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Girotra, Priti
Singh, Shailendra Kumar
Funding for this research was provided by:
Department of Science and Technology, New Delhi (IF130145)
Text and Data Mining valid from 2016-03-22